The exceptions were NRAS and CDK6 (both with only a trend for higher expression), TYRP1, and TERT. Upstream breakpoints have been reported to increase expression of TERT due to mechanisms such as enhancer hijacking in other cancer types36,37 and are also proposed to occur in AM7. This evidence concerns the gene CDK6 and cancer.